Effectiveness of a palliative care outpatient programme in improving cancer-related symptoms among ambulatory Brazilian patients

Paiva, Carlos Eduardo; Faria, Catarina; Nascimento, Maria Salete de Angelis; Santos, Renata dos; Scapulatempo, Heloisa Helena; Costa, Everaldo Donizete; Paiva, Bianca Sakamoto Ribeiro

doi:10.1111/j.1365-2354.2011.01298.x

Cited by 23 publications

(29 citation statements)

References 23 publications

(51 reference statements)

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Several studies confirm association between pain, anxiety, depression (Landi et al, ; Utne et al, ) and fatigue (Paiva et al, ). Some presented the relationship between pain and anxiety (Mystakidou et al, ) and some between pain and depression (Bair et al, ; Kim, Malone, & Barsevick, ; Laird, Boyd, Colvin, & Fallon, ; Landi et al, ).…”

Section: Discussionmentioning

confidence: 83%

Pain, fatigue, anxiety and depression in older home‐dwelling people with cancer

et al. 2019

View full text Add to dashboard Cite

AimGlobally, cancer incidence counts for more than 14 million cases and the number increases with age. The aim of this study was to investigate the occurrence of pain, fatigue, anxiety and depression in association with demographic and clinical factors.DesignA cross‐sectional descriptive design was used.MethodsWe performed descriptive statistics to analyse the questionnaires completed from 174 older home‐dwelling people with cancer.ResultsThe people with cancer reported low occurrence of pain, fatigue, anxiety and depression. We found strong correlation between anxiety and depression. Women reported significantly higher scores of anxiety and depression than men. A higher pain score was associated with higher scores of fatigue and anxiety.ConclusionsHome care personnel meeting older home‐dwelling people with cancer should emphasize these people’ mental health problems and be aware that pain, fatigue and anxiety may occur at the same time.

show abstract

Section: Discussionmentioning

confidence: 83%

Pain, fatigue, anxiety and depression in older home‐dwelling people with cancer

et al. 2019

View full text Add to dashboard Cite

show abstract

“…The advantages and limitations of ESAS are shown in Table 3. ESAS is currently used for symptom screening and monitoring in different palliative care settings, including inpatients,(52–54) outpatients,(55–58) and home care. (17) Within other branches of oncology, ESAS has been used by medical oncologists,(59, 60) radiation oncologists,(61) surgical oncologists,(62, 63) and gynecological oncologists.…”

Section: Present Applicationsmentioning

confidence: 99%

The Edmonton Symptom Assessment System 25 Years Later: Past, Present, and Future Developments

Hui

Bruera

2017

Journal of Pain and Symptom Management

534

428

View full text Add to dashboard Cite

Context Routine symptom assessment represents the cornerstone of symptom management. ESAS is one of the first quantitative symptom assessment batteries that allows for simple and rapid documentation of multiple patient-reported symptoms at the same time. Objective To discuss the historical development of ESAS, its current uses in different settings, and future developments. Methods Narrative review Results Since its development in 1991, ESAS has been psychometrically validated and translated into over 20 languages. We will discuss the variations, advantages and limitations with ESAS. From the clinical perspective, ESAS is now commonly used for symptom screening and longitudinal monitoring in patients seen by palliative care, oncology, nephrology, and other disciplines in both inpatient and outpatient settings. From the research perspective, ESAS has offered important insights into the nature of symptom trajectory, symptom clusters and symptom modulators. Furthermore, multiple clinical studies have incorporated ESAS as a study outcome and documented the impact of various interventions on symptom burden. On the horizon, multiple groups are actively investigating further refinements to ESAS, such as incorporating it in electronic health records, employing ESAS as a trigger for palliative care referral, and coupling ESAS with personalized symptom goals to optimize symptom response assessment. Conclusion ESAS has evolved over the past 25 years to become an important symptom assessment instrument in both clinical practice and research. Future efforts are needed to standardize this tool and explore its full potential to support symptom management.

show abstract

“…This study was conducted in Barretos Cancer Hospital (BCH; São Paulo, Brazil) which has a unit dedicated only to PC where patients with advanced cancer are treated with either PC exclusively or antineoplastic treatment in conjunction with PC [11]. At the time of study inclusion, data regarding previous follow-ups in PC and also regarding the last receipt of antineoplastic systemic treatment were retrieved from the patients' medical records.…”

Section: Setting Study Design and Eligibility Criteriamentioning

confidence: 99%